Saifee Hospital organises oncology conference in Tata Memorial Hospital
The conference addressed the needs of both beginners and experienced peritoneal surface oncologists providing a comprehensive update on the current standards of care in the field as well as the emerging therapies
Saifee Hospital recently organised an international conference on ‘Annual Update in Peritoneal Surface Oncology’ at the Tata Memorial Hospital. The conference addressed the needs of both beginners and experienced peritoneal surface oncologists providing a comprehensive update on the current standards of care in the field as well as the emerging therapies.
The three-day extensive scientific programme had the best in the field from around the world who conducted interesting sessions including the basics, topics of debate and the new developments in this field, through lectures, training workshops and case study discussions. Video sessions and live surgeries were performed by the experts that were streamed live from the operation theatre in Saifee Hospital. The highlight of the programme was live surgical demonstration conducted by Dr Paul Sugarbaker, well-known for developing the principles of peritoneal cancer surgery.
The primary objective of this initiative was to educate and collaborate with fellow practitioners and experts. Based on registry statistics, Mumbai alone has more than 2000 patients that have this aggressive form of the disease, where standard treatment modalities give poor results. The idea is to create awareness of the medical fraternity, to help in early diagnosis so that patients could be referred to a high volume centre for better treatment.
Dr Sanket Mehta, Chief of Division of Peritoneal Surface Oncology, Saifee Hospital & President of Society of Peritoneal Surface Oncology, India said, “Our objective is to create a credible industry platform and assimilate some of the greatest talents from the world at one point and exchange the latest developments and learnings in the field. The exchange of knowledge from the experts around the world certainly would provide an edge to the new doctors and other medical practitioners in the field of oncology.”